Ironwood Pharmaceuticals IRWD
NASDAQ IRWD
$4.07 -0.10 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019)

Ironwood Pharmaceuticals' (IRWD) quarterly Finished Goods came in at $191000.0 in Q4 2019, down 58.21% quarter-over-quarter from $457000.0 in Q3 2019.

Analysis

Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Finished Goods across 3 years of filings, most recently posting $191000.0 for Q4 2019.

  • In Q4 2019, Finished Goods changed N/A year-over-year to $191000.0; the TTM figure through Dec 2019 stood at $191000.0 (changed N/A YoY), while the FY2019 annual figure was $191000.0, changed N/A from the prior year.
  • Finished Goods came in at $191000.0 for Q4 2019 at Ironwood Pharmaceuticals, down from $457000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $1.4 million in Q1 2018 to a low of $76000.0 in Q3 2018.
  • Average Finished Goods over 3 years is $589428.6, with a median of $479000.0 recorded in 2017.
  • Year-over-year, Finished Goods sank 84.13% in 2018 and jumped 501.32% in 2019.
  • Over 3 years, Finished Goods stood at $735000.0 in 2017, then slumped by 89.66% to $76000.0 in 2018, then jumped by 151.32% to $191000.0 in 2019.
  • Per Business Quant data, the three most recent Finished Goods figures were $191000.0 in Q4 2019, $457000.0 in Q3 2019, and $76000.0 in Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Ironwood Pharmaceuticals 669.13 Mn 590.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 191,000.00
Sep 30, 2019 457,000.00
Sep 30, 2018 76,000.00
Jun 30, 2018 791,000.00
Mar 31, 2018 1.40 Mn
Dec 31, 2017 735,000.00
Sep 30, 2017 479,000.00